Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002576149 | SCV002931810 | likely benign | not provided | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002576149 | SCV003842710 | uncertain significance | not provided | 2022-09-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Occurs in the triple helical domain at the Y position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the Y position is not a common mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004973439 | SCV005569030 | uncertain significance | Inborn genetic diseases | 2024-11-21 | criteria provided, single submitter | clinical testing | The c.1757A>G (p.H586R) alteration is located in exon 24 (coding exon 23) of the COL4A4 gene. This alteration results from a A to G substitution at nucleotide position 1757, causing the histidine (H) at amino acid position 586 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005019232 | SCV005649161 | uncertain significance | Autosomal recessive Alport syndrome; Hematuria, benign familial, 1 | 2024-01-22 | criteria provided, single submitter | clinical testing |